Connect your AI

SION SION Compensation and benefits

Compensation and benefits at other companies

Denali Therapeutics Inc.DNLI

——

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

Operating income-$29.6M-50.6%

Net income-$26.8M-62.5%

EPS (diluted)-$0.60+3.2%

Balance sheet

Cash & equivalents$64.3M-23.2%

Total debt$8.4M-11.8%

Total equity$288.2M-18.1%

Total assets$305.0M-17.5%

Cash flow

Operating cash flow-$21.8M-34.1%

CapEx--100%

Free cash flow-$21.8M-33.4%

Valuation

Market cap$1.86B—

Returns & leverage

Return on equity-26.7%—

Debt / equity0×0.0×

Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is SION's compensation and benefits?: SION (SION) reported compensation and benefits of $1.49M in Q1 2026.
How has SION's compensation and benefits changed year-over-year?: SION's compensation and benefits increased by 51.0% year-over-year, from $989K to $1.49M.